ArticlemicroPublication biology2026
LMO2 regulates STAT3 localization to the nucleus in breast cancer cells.
Article in microPublication biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
STAT3 phosphorylation and transcriptional activity promote breast cancer growth and metastasis. We have previously reported that the transcriptional adaptor LMO2 is required for metastasis in breast cancer and promotes STAT3-JAK2 interaction, leading to STAT3 phosphorylation in metastasis-initiating cells. Here, we find that constitutively activated STAT3 is insufficient to drive metastasis in the absence of LMO2. Mechanistically, we find that LMO2 is required not only for STAT3 phosphorylation in the cytoplasm but also for STAT3 translocation to the nucleus. These data suggest that LMO2 promotes STAT3 activation and localization to the nucleus in breast cancer cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.